Clinical trials

  • Doxorubicin hydrochloride for High-grade soft tissue sarcoma
  • Bacteriophage for Urinary tract infection | Neurogenic bladder
  • (S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-CYANO-4,4-DIFLUOROPYRROLIDIN-1-YL)-2-OXOETHYLCARBAMOYL)-QUINOLIN-6-YL)(METHYL)AMINO)-PROPYL)PIPERAZIN-1-YL)-2-OXOETHYL)-68GA-[1,4,7,10]-TETRAAZACYCLODODECANE-1,4,7-TRIYL)TRIACETATE for Malignant melanoma
  • NIRMATRELVIR for COVID-19 | SARS-CoV-2 infection
  • ADALIMUMAB for Rheumatoid arthritis
  • Heparin sodium for Multiple myeloma | Lymphoma
  • Clinical trial in Advanced PRAME-positive cancers|Malignant melanoma|Synovial sarcoma|Non-small cell lung cancer|Cholangiocarcinoma|Small cell lung cancer|Adenoid cystic carcinoma|Endometrial cancer|Clear cell endometrial carcinoma|Papillary serous endometrial carcinoma|Ovarian cancer|Uterine cancer
  • Methylprednisolone acetate (and lidocaine hydrochloride monohydrate listed in product substances) for Acute alcoholic hepatitis | Severe acute alcoholic hepatitis
  • BINTRAFUSP ALFA for Soft-tissue sarcoma | Locally advanced or unresectable soft-tissue sarcoma | Metastatic soft-tissue sarcoma
  • pembrolizumab for Melanoma (resected, Stage IIB–III)
  • Tocilizumab for Chronic pancreatitis
  • RESIQUIMOD SULFATE for Pancreatic cancer|Virus-associated tumors|Non-small cell lung cancer|Soft-tissue sarcoma|Bladder cancer|Triple-negative breast cancer